|Articles|June 1, 2013
Atypical presentation of acute macular neuroretinopathy
A case report
Advertisement
The clinical examination
BCVA: 10/10 (0.0 LogMar) with sf –1.00 = cyl –3.50 (90)
Ocular pressure: 11 mmHg
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: Port delivery system shows reliable 6-month durability and sustained efficacy in neovascular AMD for up to 7 years
2
FLORetina 2025: Artificial intelligence at the frontlines of ROP care
3
FLORetina 2025: Navigating antithrombotic therapy in wet AMD
4
FLORetina 2025: Rethinking Terson syndrome through multimodal imaging
5









































